This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Il Dong Pharmaceutical Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Seolhee Lee: Innovator in CFTR Modulation
Introduction
Seolhee Lee is a prominent inventor based in Hwaseong, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate the cystic fibrosis transmembrane conductance regulator (CFTR).
Latest Patents
Seolhee Lee holds a patent for "Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators." This patent provides CFTR modulator and phosphodiesterase 4 (PDE4) inhibitor compounds, which can be utilized for treating eye diseases and CFTR-related indications. The compounds described in the patent offer methods for modulating CFTR functionality and inhibiting PDE4 in biological systems.
Career Highlights
Seolhee Lee is associated with Il Dong Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in innovative therapeutic solutions. His work focuses on creating effective treatments for various diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Seolhee Lee collaborates with talented colleagues, including Jungho Kim and Jung Woo Lee. Their combined expertise fosters a productive research environment that drives innovation in pharmaceutical development.
Conclusion
Seolhee Lee's contributions to CFTR modulation and his innovative approach to pharmaceutical research highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in treating complex diseases.